Roche Holding AG is nearing a deal to buy Philadelphia biotech company Spark Therapeutics Inc., according to people familiar with the matter, as the Swiss drugmaker seeks to expand its presence treating hemophilia.
WSJ.com: Asia Home, Wall Street Journal: Home Asia
Sat, 02/23/2019 - 1:09pm
Roche Holding AG is nearing a deal to buy Philadelphia biotech company Spark Therapeutics Inc., according to people familiar with the matter, as the Swiss drugmaker seeks to expand its presence treating hemophilia.